CastleArk Management »

Immunovant shares owned by CastleArk Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by CastleArk Management from 13F filings

Historical chart of CastleArk Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by CastleArk Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by CastleArk Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.6M 80k 32.31

More positions owned by CastleArk Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Servicenow (NOW)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
Dex (DXCM)
Lam Research Corporation (LRCX)
Visa Com Cl A (V)
Intuitive Surgical Com New (ISRG)
Stryker Corporation (SYK)
Applied Materials (AMAT)

View all positions for CastleArk Management

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Viking Global Investors
Perceptive Advisors
Alpine Partners VI
Woodline Partners
T. Rowe Price Investment Management
Geode Capital Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Pictet Asset Management Holding SA

View all funds holding Immunovant